Načítá se...
The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers
BACKGROUND: Limited data exist on the real‐world costs of applying whole‐genome analysis (WGA) in a clinical setting. We estimated the costs of applying WGA to guide treatments for patients with advanced cancers and characterized how costs evolve over time. METHODS: The setting is the British Columb...
Uloženo v:
| Vydáno v: | Mol Genet Genomic Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5441418/ https://ncbi.nlm.nih.gov/pubmed/28546995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.281 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|